Newsfeeds - Spark Newswire

2 minute read

Cara Therapeutics Announces Results From The KOMFORT Phase 2 Trial Of Oral Difelikefalin For The Treatment Of Pruritus In Notalgia Paresthetica Published In The New England Journal Of Medicine

Today, 8:08 AM

Cara Therapeutics, Inc. (NASDAQ:CARA), a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced the New England

CARA

1 minute read

Cannabis Stock Movers For December 23, 2022

By Benzinga Insights

Today, 8:08 AM

GAINERS: Trulieve Cannabis (OTC:TCNNF) shares closed up 14.05% at $7.58 Curaleaf Holdings (OTC:CURLF) shares closed up 10.00% at…

CARA

13 minute read

Earnings

Earnings Scheduled For November 7, 2022

By Benzinga Insights

Today, 8:08 AM

Companies Reporting Before The Bell • NAPCO Security Techs (NASDAQ:NSSC) is expected to report quarterly earnings at $0.13 per share on revenue of $36.34 million.

AAON

1 minute read

Cannabis Stock Gainers And Losers From November 2, 2022

By Benzinga Insights

Today, 8:08 AM

GAINERS: LOSERS: RIV Capital (OTC:CNPOF) shares closed down 12.25% at $0.30

ACB

1 minute read

Cannabis Stock Gainers And Losers From September 21, 2022

By Benzinga Insights

Today, 8:08 AM

GAINERS: Icanic Brands (OTC:ICNAF) shares closed up 18.62% at $0.07

ACB

1 minute read

Marijuana Stock Movers For September 19, 2022

By Benzinga Insights

Today, 8:08 AM

GAINERS: Icanic Brands (OTC:ICNAF) shares closed up 16.92% at $0.08

CARA

1 minute read

Cara Therapeutics Presents Results of Oral Difelikefalin In Painful Itching Disorder

By Vandana Singh

Today, 8:08 AM

Cara Therapeutics Inc (NASDAQ:CARA) announced results from the KOMFORT Phase 2 clinical trial of oral difelikefalin for moderate-to-severe pruritus in notalgia…

CARA